Alaunos Therapeutics Inc (TCRT) Quote

TCRT under $2

TCRT..................................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

TCRT: effective Feb. 1,2024 a one for 15 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php

What's the deal with this bio

TCRT..............................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

LFG

TCRT.........................................https://stockcharts.com/h-sc/ui?s=TCRT&p=W&b=5&g=0&id=p86431144783

Would like to see an ATH.

The PUMP has begun

Let’s pump this $.12 themed bottom stock we saw many $.12 runners AGRI PVLP LIFW MIMO AWIN why not this?

In my view, throwing more good money into a bad money situation amounts to gambling
We’re currently in a bull market for mature companies which is how I am spreading my money around

Opportunity or lost cause?

TCRT new 52 week low

TCRT new 52 week low

They filed an 8-K:

https://www.bamsec.com/filing/119312522254857?cik=1107421

I can not find any article or info from 9/30 presentations….

3$+ this week

Lol... good for you my friend. Hope you all make some retirement money

Watch on Sept 30. Boom. To Uranus and beyond

Thank you for asking, “UP 140%!”

But because I bought at $0.65, expiring Oct. 21 $2.50 call before the drop, I am still down more than 30%, haha, but I am happy to see TCRT going back up!

Let’s gooooo!

How's that call option looking today?

Ouch, I got killed today. I bought option call and the value became only half now…
Good luck everyone. I am still hoping for good presentation on 9/30/22. This needs to turn around.

I hope the presentation to be amazing on 9/30/22.

Thank you, and sorry my slow reply.

I regret I do not have the full subscription for private replies.

Is it still the case people like me can PM on Friday’s from 4-5 pm EST?

If so, let’s connect then.

You seem to have s good grasp of the field, at present. God knows this area of Science/Practice needs HELP.

My friend found this yesterday

CRT's stock is down on heavy volume as a blog post from the husband of treated
Patient #2 reported that she has stopped therapy due to a mutation
(https://www.givesendgo.com/Woldt). While social media post are not company
press releases and in the vast majority of situations must be taken with a grain of
salt, there appears to be some validity here. With data from the objective response
(OR) seen in Patient #1 - who has lung cancer - about to be presented on
September 30, we are buyers of TCRT here on weakness. BUY.
Details from GoFundMe Blog
Now all of this from the unsolicited blog/link above. The woman has advanced
colon cancer which was targeted with P53 mutation from the TCR-T Library. She
started treatment late-Spring/early Summer that initially resulted in a 27% tumor
reduction. The mutation appears to have occurred after recent blood work was
performed at MD Andersen. A mutation in colon cancer is not unheard of as colon
cancer is known to often mutate when under pressure, i.e. chemotherapy.
Importantly and despite the setback in treatment, the patient is healthy enough to
resume chemotherapy and did not appear to suffer any platform-related side
effects that might have a negative read through to TCRT. Hence is the beauty of
the Alaunos' Sleeping Beauty kill switch and stopping the overactive immune
response before it gets out of control. As a reminder, all of this is unconfirmed
although the blog and its details appear legit.

Patient #1 Is Key

Most importantly, Alaunos recently confirmed that it has seen an objective partial
response (OR) in the first patient treated in the study. Patient #1 has non-small c
lung cancer, and had one prior line of adjuvant therapy following surgery and thre
prior lines of systemic therapy. The patient has a tumor with a KRAS G12D
mutation, not P53. The patient was treated at the first dose level with TCR-T cells.
an objective response was observed and has now cleared the 28-day safety
window. TCRT will report initial data from the study on Friday, September 30,
8:30am ET at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy
Conference.

A LOT MORE TO COME

In our view, the TCR-T platform has the ability to treat solid tumors with CAR-T
therapy, and the setback with Patient #2 will be a learning event for the Company.
The proprietary safety kill switch is a life saver in immuno-oncology. With only two
very late-stage patients having been treated, a 50% overall response rate (ORR)
would be more than acceptable.
The Company is advancing it's TCR-T Library Phase 1/2 trial targeting KRAS,
TP53 and EGFR mutations across six solid tumor indications, obviously the first
being lung, the second colorectal. We expect the upcoming detailed data from
Patient #1 will be positive and help the stock to regain its momentum. As we know
that different tumors respond differently and this is a very small sample size we are
dealing with; hence, the wild volatility in TCRT shares. However, we know for sure
that the platform has resulted in at least one objective response in a very advanced
lung cancer patient at the first dose, and that patient has been cleared by the FDA
to advance to the next dose. We are buyers on this weakness.

ONE PERSON? Starts a 50% share price drop? Something is f up here

from td news feed 12:46 pm.
trading lower on circulation of a post on ...give.send.go... from a patient in tcr-t library phase1/2 trial.

didnt see the comment, but the patient must have had some side effects ...or worse , i would guess , for this stock to be taking such a beating

I hope so, Good Luck!

Coming back down now. I hope my feeling or intuition is right. Good luck to you.

Hmm

I’d say you did very well.

Yeah, need to check broker bid/ask. I tried to catch falling knife and I caught it. I hope I don’t cut my hands badly. I usually cut my hands really deep, haha.

Not necessarily. It might have to do with their recent prospectus to raise $50M.

Yes, I see now - iHub Data feed and chart were not accurate when I asked that question, (it was showing 1.44 low). Also bid/ask not accurate as shown on iHub.

Looks like data Tcrt was going to present on sept 30 might have leaked out as No good jmho. But down 50% when they have been up 13 months!! Think it’s gonna go to .50 soon

They lost(-$0.25) last 12 month. That is why. I see to take advantage of this is great idea at $1.30. If much higher price, I am not sure short term.

Down 50%? Then something very wrong. Whatever they had to produce and get approval I think is scrubbed. Only reason for down $1.50 and halted. Simple. Oh well another loss.

No, I put limit order at $1.30, luckily it got filled. It went down as low as $1.26. I was thinking to sell, but I decide to keep to see what is coming in the future. I like to take chance.

Did you mean 1.50?

I saw that and it is not halted anymore, so I added my position at $1.30. If the final stage results are good and approved, TRCT lost $0.25 last 12 month should be nothing, but just buying opportunity here. Future should be bright. We will see.

Now down -51%!

…

TCRT lost -$0.25 last 12 month. Time to buy more.

What did just happen ? Down 33%?

Don’t think we see 4’s for another 4 weeks. Damn

Been up last 6 months. I buy today. Down. Bad luck. Still think great company

Looks like we will break into the 4’s today

Nice day today. Blue skies!

We break 2.60 and it’s ok!! GL

2.30’s here

Nice to see the 2’s broken